A Matter of Trust: Johnson & Johnson Product Recalls
[2023-09-17 09:49:30]
At the end of 2010, Johnson & Johnson (J & J) faced several quality-related issues, including product defects found in pharmaceuticals manufactured by a division of McNeil Consumer Healthcare (MNCH) in the United States of America. Johnson & Johnson, which adopted the crisis management approach, was still regarded as a gold standard for brand crisis management since the 1982 Tylenol crisis, but this time it got into a wrong fix. The company was strongly criticized for lack of quick response to various products intended for adults, children, babies who were regarded as out of the standards. The Food and Drug Administration (FDA), a consumer and industry regulatory agency, has repeatedly complained, but Johnson & Johnson's quality control is still mistaken.
The company has also been condemned by taking slow and inappropriate measures to correct quality defects. Some critics condemned Johnson trying to conceal the problem with secret product recovery. William Wilden, CEO of Johnson & Johnson, acknowledged MNCH's mist for the first time after its criminal investigation by industry regulators and oversight of the US Congress and a series of hearings on the Government Reform Committee (HCOGR). Many people think that admission time is too late, especially according to standards set by the company previously. Observer pointed out that this is quite different from Johnson & Johnson. And it has caused widespread criticism from society, regulators and the government. Brand reputation was further hit when three factories were acquired by the FDA and failed to comply with the mandatory quality standards agreed to resolve the law.
After a series of setbacks, the company's CEO vowed to regain the reason for the loss by reinvesting and creating a new position to oversee compliance with the quality control of the entire group. However, experts believe that while the corrective action may help Johnson & Johnson settle quality problems, the biggest challenge is regaining consumer confidence and getting high prices . There is a report that consumers began switching to other competitive and inexpensive brands.
This case is ideal for brand management, brand crisis management, supply chain crisis management, quality control, corporate social responsibility (CSR), marketing, strategy, business ethics. It can also be used to explain to some extent the importance of the corporate governance system and the structure and management of the organization.
The target audience for this case is an audience of master's and doctoral programs in business administration, MSc programs, marketing, brand management, supply chain management, and control programs.
Brand Crisis Management, Crisis Management, Corporate Social Responsibility, Brand Crisis Management Gold Standard, Johnson & Johnson, Product Recovery, Supply Chain Risk Management, USA Tylenol
Johnson & Johnson is considered a gold standard to remember Tylenol and has been used as a perfect example for many years. Johnson & Johnson is responsible for using everyone's product. It is important for companies to clearly communicate with the public, observe government officials, investigate products, and collect them. Unfortunately, Johnson & Johnson has the problem of paying rebate brokers using their products. This is a situation that has been going on for many years. At this point, Johnson & Johnson remembered its products (2010 and 2011). According to their recent and past actions, Johnson & Johnson can no longer be used as a gold standard for ethical behavior.
The leaders of Johnson & Johnson showed a clear response. James E. Burke announced the nationwide recall of the bottle. It reminded me of an abnormality that raised consciousness, informed consumers about the event, and started an event to create new things. Packaging to prevent product tampering Typical response to this crisis is a direct result of Johnson & Johnson's employees, leadership and culture. Patagonia shows honesty thr